US CDMO developments: Genezen further expands lentiviral and retroviral vector production site, Wheeler Bio closes Series A round 04-Oct-2022 By Jane Byrne Genezen has completed another expansion phase at its viral vector process development and cGMP vector production facility in Fishers, Indiana.